Monday, July 28, 2014 Last update: 9:33 AM
FreshNews.com - All Company Technology News Since 1996

Arrowhead to Present at Barclays Global Healthcare Conference

Companies mentioned in this article: Arrowhead Research Corporation

PASADENA, Calif. -- (BUSINESS WIRE) -- Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that President and CEO, Christopher Anzalone, Ph.D., will present at the Barclays Global Healthcare Conference on Thursday, March 13, 2014 at 8:00 a.m. EDT at the Loews Hotel in Miami, Florida.

A live webcast of the presentation can be accessed by visiting the News & Events section of the company’s website, http://www.arrowheadresearch.com/presentations. A replay will also be archived on the website.

About Arrowhead Research Corporation

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and partner-based programs in obesity and oncology.

For more information please visit http://www.arrowheadresearch.com, or follow us on Twitter @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to ir@arrowres.com.


Copyright © Business Wire 2014
Contact:

Arrowhead Research Corporation
Vince Anzalone, CFA
626-304-3400
ir@arrowres.com
or
The Trout Group
Lauren Glaser
646-378-2972
ir@arrowres.com